Fundz

Spliceor has received funding from Cell and Gene Therapy Catapult to accelerate its gene therapy platform for liver cancer under the Cross-Catapult Investment Pilot.

PRIVATEJul 29, 2025

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Innovate UKCell And Gene Therapy Catapult

Description

Spliceor has secured funding as part of the Cross-Catapult Investment Pilot led by the Cell and Gene Therapy Catapult. This investment will aid in the pre-clinical development of its innovative gene therapy for liver cancer. The support also aims to build out the team and further validate this potential life-saving treatment. With this investment, the CGT Catapult seeks to enhance the pipeline of advanced therapies within the UK.

Quick answer

Spliceor raised an undisclosed amount in a Seed round, dated July 29, 2025. Investors: Innovate UK and Cell And Gene Therapy Catapult.

How much did Spliceor raise?
Spliceor raised an undisclosed amount in a Seed round on July 29, 2025.
Who invested in Spliceor?
Innovate UK and Cell And Gene Therapy Catapult are named as investors in this round.
What does Spliceor do?
Spliceor is an innovative advanced therapies company and a spinout from the University of Cambridge.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Spliceor that raised within 45 days of this round, from Fundz verified event records.

  • Alchemab Therapeutics raised an undisclosed amount (Series A) on September 9, 2025.
  • iRegene Therapeutics raised an undisclosed amount (Series B) on September 9, 2025.
  • NRG Therapeutics raised $67M (Funding Round) on September 8, 2025.
  • Integra Therapeutics raised $13M (Funding Round) on September 8, 2025.
  • MRM Health raised $64M (Series B) on September 4, 2025.
  • TNF Pharmaceuticals raised $7M on September 2, 2025.

Who to call at Spliceor, and when

A new round usually means Spliceor is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Spliceor raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spliceor, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spliceor. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spliceor

About

Spliceor is an innovative advanced therapies company and a spinout from the University of Cambridge. It specializes in developing trans-splicing gene therapy platforms aimed at treating liver cancer and other indications. The company's technology has the potential to significantly impact cancer treatment, specifically for patients diagnosed with liver cancer. Its goal is to deliver more specific and effective gene therapies that advance toward clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spliceor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Spliceor's next move

See what Strategic adds

Spliceor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.